PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Membranous expression of target protein is required for ADC response in urothelial cancer (2024) Klümper N, Brägelmann J, Bahlinger V, Hartmann A, Grünwald V, Kuppe C, Hölzel M, Eckstein M Journal article Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy. (2024) van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, et al. Journal article Das muskelinvasive und metastasierte Urothelkarzinom der Harnblase: Aktueller Stand histopathologischer, molekularer und immunologischer Prognose- und Prädiktionsfaktoren (2024) Bertz S, Bahlinger V, Lange F, Hartmann A, Eckstein M Journal article Biomarker-stratified first-line treatment of right-sided metastatic colon cancer with interdisciplinary collaboration in the IVOPAK II trial (2024) Vitali F, Merkel S, Schubart C, Schmid A, Eckstein M, Stöhr R, Kersting S, et al. Journal article Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer (2024) Lange F, Geppert CI, Bahlinger V, Bertz S, Stöhr R, Sikic D, Taubert H, et al. Journal article An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer (2024) Reike MJ, Reicherz A, Tully KH, Bahlburg H, Maas M, Bach P, Klümper N, et al. Journal article On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy. (2024) Saal J, Grünwald V, Bald T, Ritter M, Brossart P, Tomita Y, Hartmann A, et al. Journal article Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor (2024) Haas M, Kriegmair MC, Breyer J, Sikic D, Wezel F, Roghmann F, Brehmer M, et al. Journal article Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial Cancer (2024) Klümper N, Eckstein M Journal article, Review article Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer (2024) Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V Journal article